Skip to search formSkip to main contentSkip to account menu

saruplase

Known as: prourokinase (enzyme-activating), recombinant unglycosylated single-chain urokinase-type plasminogen activator, pro-urokinase 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2002
2002
We have examined the effect of glycosylation on the traffic of the voltage-gated Shaker potassium channel through the secretory… 
Review
2001
Review
2001
Summary Successfully utilized contemporary pulmonary embolism thrombolysis reverses right heart failure rapidly and safely. This… 
1998
1998
Summary In a single centre pilot study, saruplase (20 mg bolus plus 60 mg infusion over 1 h) was administered to twenty patients… 
1997
1997
Summary Background: The recombinant unglycosylated single chain urokinase-type plasminogen activator saruplase is cleared for a… 
1993
1993
Summary Pharmacokinetics of two doses of the recombinant single-chain urokinase-type plasminogen activator (r-scu-PA) saruplase… 
1990
1990
The production of prourokinase (PUK) by a human kidney tumor cell line is studied in long term cultures. Cells are grown on… 
1990
1990
In anesthetized rabbits with pulmonary embolized thrombi the interactions of saruplase (recombinant unglycosylated single-chain… 
1990
1990
The thrombolytic efficacy of recombinant unglycosylated full length single chain urokinase-type plasminogen activator (rscu-PA…